Meeting Biology’s “Sputnik Moment”
Summary
Biology is becoming a defining technology of the modern era: the bioeconomy is expected to contribute nearly 1.1 million jobs to the United States by 2030. Preparing the skilled workforce that our nation will need to fill these jobs requires a fundamental shift in how the field of biology is viewed. Biology is not merely a collection of facts to be memorized in school. Rather, it is a dynamic economic sector that provides opportunities for Americans of all skillsets, and that can generate creatively engineered solutions to persistent global challenges.
The Biden-Harris Administration can position the United States as a world leader in the emerging bioeconomy by funding modernized biology education, establishing world-class entrepreneurial hubs for biotechnology in non-traditional regions of the country, and supporting equitable access to industry-recognized certificates and work-based training. Through this comprehensive Built with Biology Plan, the federal government can prepare and invite more Americans into skilled jobs that support the bioeconomy. The social imperative for investing in the bioeconomy is at least as great as the economic one. We will build a better future for all Americans—including people of color, people with disabilities, and people from economically disadvantaged backgrounds—only by harnessing regional talent and growing robust bioeconomies in all 50 states.
The space economy is enormous, but one of its biggest challenges is tiny: space debris.
The U.S. would need 65,000 miles of pipeline to achieve net-zero emissions by 2050. Here’s how the Biden Administration can expanding the use of low-emission, composite materials to support a net-zero vision.
Amino acids are essential but costly inputs for large-scale bioproduction. Federal funding can incentivize scalable production, cutting these costs in half.
Investing in oxygen as a utility through on-demand infrastructure can improve access and mortality rates globally. Healthcare experts propose how an international coalition led by USAID can transform the medical oxygen marketplaces of low- and middle-income countries to ensure every patient has the oxygen they need.